NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL ...
GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China, the Piscataway-headquartered company announced May 18. Located in the city of ...
NANJING, China, July 17, 2019 /PRNewswire/ -- GenScript Biotech Corp., one of the leading Biologics contract development and manufacturing organizations (CDMOs) in China, today announced that its ...
The rapid advancements in cancer immunotherapy have positioned bispecific antibodies (BsAbs) and T-cell engagers (TCEs) as transformative therapeutic strategies. However, the development of these ...
SEOUL, Korea--(BUSINESS WIRE)--GenScript ProBio, a global multimodality CDMO and NuclixBio, a company developing treatments based on circular RNA, announced on 9th Nov that they have entered into a ...
SINGAPORE, April 23, 2024 /PRNewswire/ -- GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming ...
CDMO ProBio, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of new manufacturing facility in Hopewell, New Jersey. The site, ...
NANJING, China and SAN DIEGO, June 2, 2021 /PRNewswire/ -- GenScript Biotech Corporation (HKG: 1548) along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results